Literature DB >> 23024473

Serum cytokine profile in psoriasis-a case-control study in a tertiary care hospital from northern India.

Bincy Verghese1, Sonu Bhatnagar, Ramchander Tanwar, Jayashree Bhattacharjee.   

Abstract

Psoriasis is chronic autoimmune hyperproliferative skin disease with a population prevalence of 1.5-3%. The cause of psoriasis is still not fully understood. It has been hypothesized to be an immune-mediated disorder in which the excessive reproduction of keratinocytes is due to cytokines such as interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha, secreted by infiltrating CD4(+) and CD8(+) T cells and natural killer cells. The aim of our study was to determine the serum levels of TNF-α, IL-4, IL-6 &amp; IL-10 in psoriasis patients and compare it with healthy controls. 30 clinically diagnosed psoriasis patients and 30 age and sex matched healthy controls were included in the study. The serum cytokine levels were measured by solid phase sandwich ELISA (DIACLONE Research, France). TNF-α and IL-6 levels were significantly raised in patients and the results were statistically significant (P < 0.001). IL-4 levels were higher in patients than in controls (1.91 ± 4.7 pg/ml in cases &amp; 0.9 ± 0.3 pg/ml in controls) but were not statistically significant. Interestingly, IL-10 levels were found to be higher in controls than in patients but again, it was not statistically significant. Pro-inflammatory cytokines play a pivotal role in the pathogenesis of psoriasis and it is the type 1(TH1) cytokine pattern, i.e., IL-6 &amp; TNF-α, which predominate in the psoriatic T cell response. Further studies on IL-10 levels in psoriasis are recommended to establish their exact role in the pathogenesis of the disease.

Entities:  

Keywords:  Cytokines; Interleukins; Psoriasis; TNF-alpha

Year:  2011        PMID: 23024473      PMCID: PMC3210248          DOI: 10.1007/s12291-011-0156-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  17 in total

Review 1.  Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression.

Authors:  Wook Lew; Anne M Bowcock; James G Krueger
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

Review 2.  Current concepts in the immunopathogenesis of psoriasis.

Authors:  Michelle A Lowes; Wook Lew; James G Krueger
Journal:  Dermatol Clin       Date:  2004-10       Impact factor: 3.478

3.  [Interleukin-6 as a marker of the activity of a pathological process in patients with psoriasis].

Authors:  V H Koliadenko; P V Chernyshov
Journal:  Lik Sprava       Date:  2005 Jul-Sep

4.  The pathogenic role of tissue-resident immune cells in psoriasis.

Authors:  Onur Boyman; Curdin Conrad; Giulia Tonel; Michel Gilliet; Frank O Nestle
Journal:  Trends Immunol       Date:  2007-01-02       Impact factor: 16.687

Review 5.  Biological properties of interleukin 10.

Authors:  M Howard; A O'Garra
Journal:  Immunol Today       Date:  1992-06

Review 6.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 7.  Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesis.

Authors:  Francesca Chamian; James G Krueger
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

8.  Interleukin 4 plasma levels in psoriasis vulgaris patients.

Authors:  Anna Zalewska; Janina Wyczółkowska; Bozena Dziankowska-Bartkowiak; Anna Sysa-Jedrzejowska
Journal:  Med Sci Monit       Date:  2004-04

9.  Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.

Authors:  Ozer Arican; Murat Aral; Sezai Sasmaz; Pinar Ciragil
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

10.  Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.

Authors:  Sharon E Jacob; Mehdi Nassiri; Francisco A Kerdel; Vladimir Vincek
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

View more
  5 in total

1.  Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab.

Authors:  Lazaro E Aira; Alejandro López-Requena; Dasha Fuentes; Liset Sánchez; Teresita Pérez; Aleida Urquiza; Heber Bautista; Leopoldina Falcón; Patricia Hernández; Zaima Mazorra
Journal:  MAbs       Date:  2014-03-04       Impact factor: 5.857

2.  Serum levels of TNF- α , IL-12/23 p40, and IL-17 in psoriatic patients with and without nail psoriasis: a cross-sectional study.

Authors:  Aikaterini Kyriakou; Aikaterini Patsatsi; Timoleon-Achilleas Vyzantiadis; Dimitrios Sotiriadis
Journal:  ScientificWorldJournal       Date:  2014-12-31

3.  Evaluation of selected mechanisms of immune tolerance in psoriasis.

Authors:  Agnieszka Owczarczyk-Saczonek; Joanna Czerwińska; Małgorzata Orylska; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2019-06-19       Impact factor: 1.837

4.  Serum Levels of Tumor Necrosis Factor - alpha in Patients With Psoriasis.

Authors:  Nermina Ovcina-Kurtovic; Emina Kasumagic-Halilovic
Journal:  Mater Sociomed       Date:  2022-03

5.  Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.

Authors:  Aikaterini Kyriakou; Aikaterini Patsatsi; Timoleon-Achilleas Vyzantiadis; Dimitrios Sotiriadis
Journal:  J Immunol Res       Date:  2014-12-21       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.